KIPRC Home / Programs


Kentucky Drug Overdose Prevention Program (KDOPP)

According to CDC WONDER data, Kentucky had the 2nd highest age-adjusted 2013 drug overdose fatality rate in the nation. The state has been a leader in prescription drug monitoring program (KASPER) development and implementation to support proactive reporting and data analysis. Kentucky’s General Assembly passed seminal prescription drug overdose prevention laws in 2012, 2013, and 2015 to reduce inappropriate drug prescribing and resulting deaths, and to increase substance abuse treatment.

The goals of the Kentucky Drug Overdose Prevention Program are to:

  1. ENHANCE AND MAXIMIZE KASPER’S USE AND EFFECTIVENESS by: a) integrating KASPER with electronic health records; b) developing and delivering prescriber continuing education training; c) implementing a 100 MME warning flag on KASPER reports; d) establishing a multi-source drug overdose fatality (DOF) surveillance system; and e) conducting nonfatal PDO surveillance;

  2. INFORM COMMUNITY INTERVENTIONS by: a) providing technical assistance to high-drug overdose burden counties; b) creating a multidisciplinary data-focused Drug Overdose Prevention group (KyDOP); c) establishing the KIPRC Drug Overdose Technical Assistance Center (DOTAC); d) enhancing local health department use of drug overdose and abuse data results; and e) improving prevention education on drug overdose risk, appropriate prescribing, and naloxone use for prescribers and law enforcement in high-drug overdose burden counties; and

  3. CONDUCT POLICY EVALUATION by: a) evaluating and performing cost-benefit analysis of regulations that require KASPER queries and set profession-specific prescribing guidelines for schedule II-IV controlled substances; and b) evaluating and performing cost-benefit analysis of the law that requires decedent controlled substance testing when no other cause of death has been established.

 

Program Contact: Terry Bunn